Search Results

There are 5931 results for: content related to: Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature

  1. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2321–2330, Ayami Isonishi, Charles L. Bennett, Barbara Plaimauer, Friedrich Scheiflinger, Masanori Matsumoto and Yoshihiro Fujimura

    Version of Record online : 8 JUN 2015, DOI: 10.1111/trf.13182

  2. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment

    Transfusion

    Volume 53, Issue 12, December 2013, Pages: 3192–3202, Yuji Hori, Masaki Hayakawa, Ayami Isonishi, Kenji Soejima, Masanori Matsumoto and Yoshihiro Fujimura

    Version of Record online : 8 APR 2013, DOI: 10.1111/trf.12182

  3. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model

    Transfusion

    Volume 56, Issue 7, July 2016, Pages: 1775–1785, Eric M. Ostertag, Khalil Bdeir, Stephen Kacir, Michelle Thiboutot, Gayathri Gulendran, Lenka Yunk, Vincent M. Hayes, David G. Motto, Mortimer Poncz, X. Long Zheng, Douglas B. Cines and Don L. Siegel

    Version of Record online : 4 APR 2016, DOI: 10.1111/trf.13583

  4. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency

    Transfusion

    Ang Li, Pavan K. Bendapudi, Lynne Uhl, Ayad Hamdan, Richard M. Kaufman and Robert S. Makar

    Version of Record online : 20 JUN 2017, DOI: 10.1111/trf.14181

  5. You have free access to this content
    Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura

    Transfusion

    Volume 55, Issue 1, January 2015, Pages: 18–24, Nan Wu, Jia Liu, Shangbin Yang, Eric T. Kellett, Spero R. Cataland, Hong Li and Haifeng M. Wu

    Version of Record online : 23 JUN 2014, DOI: 10.1111/trf.12762

  6. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro

    Transfusion

    Volume 56, Issue 7, July 2016, Pages: 1763–1774, Eric M. Ostertag, Stephen Kacir, Michelle Thiboutot, Gayathri Gulendran, X. Long Zheng, Douglas B. Cines and Don L. Siegel

    Version of Record online : 4 APR 2016, DOI: 10.1111/trf.13584

  7. ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis

    Transfusion

    Chong H. Kim, Sierra C. Simmons, Lance A. Williams III, Elizabeth M. Staley, X. Long Zheng and Huy P. Pham

    Version of Record online : 23 JUN 2017, DOI: 10.1111/trf.14230

  8. Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2511–2515, Betty S. van der Veen, Rens Besseling and Mels Hoogendoorn

    Version of Record online : 26 AUG 2015, DOI: 10.1111/trf.13187

  9. Idiopathic thrombotic thrombocytopenic purpura: strongest risk factor for relapse from remission is having had a relapse

    Transfusion

    Volume 56, Issue 11, November 2016, Pages: 2819–2823, Jennifer Mai Falk and Inge Scharrer

    Version of Record online : 11 AUG 2016, DOI: 10.1111/trf.13751

  10. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura

    Transfusion

    Volume 55, Issue 4, April 2015, Pages: 756–765, Hong Hong, Wenbin Xiao, Lisa M. Stempak, Linda M. Sandhaus and Robert W. Maitta

    Version of Record online : 5 NOV 2014, DOI: 10.1111/trf.12912

  11. Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions

    Transfusion

    Volume 57, Issue 8, August 2017, Pages: 2045–2053, Yumi Yoshii, Yoshihiro Fujimura, Charles L. Bennett, Ayami Isonishi, Norio Kurumatani and Masanori Matsumoto

    Version of Record online : 12 MAY 2017, DOI: 10.1111/trf.14152

  12. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score

    Hepatology Research

    Volume 42, Issue 5, May 2012, Pages: 459–472, Hiroaki Takaya, Masahito Uemura, Yoshihiro Fujimura, Masanori Matsumoto, Tomomi Matsuyama, Seiji Kato, Chie Morioka, Hiromichi Ishizashi, Yuji Hori, Masao Fujimoto, Tatsuhiro Tsujimoto, Hideto Kawaratani, Masahisa Toyohara, Norio Kurumatani and Hiroshi Fukui

    Version of Record online : 31 JAN 2012, DOI: 10.1111/j.1872-034X.2011.00950.x

  13. You have free access to this content
    A phenotype–genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 9, September 2012, Pages: 1792–1801, R. S. CAMILLERI, M. SCULLY, M. THOMAS, I. J. MACKIE, R. LIESNER, W. J. CHEN, K. MANNS and S. J. MACHIN

    Version of Record online : 4 SEP 2012, DOI: 10.1111/j.1538-7836.2012.04852.x

  14. A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura

    Transfusion

    Volume 51, Issue 7, July 2011, Pages: 1580–1591, Yue Han, Juan Xiao, Erica Falls and X. Long Zheng

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1537-2995.2010.03020.x

  15. You have free access to this content
    Natural history of Upshaw–Schulman syndrome based on ADAMTS13 gene analysis in Japan

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue s1, July 2011, Pages: 283–301, Y. FUJIMURA, M. MATSUMOTO, A. ISONISHI, H. YAGI, K. KOKAME, K. SOEJIMA, M. MURATA and T. MIYATA

    Version of Record online : 22 JUL 2011, DOI: 10.1111/j.1538-7836.2011.04341.x

  16. Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements

    European Journal of Haematology

    Volume 88, Issue 6, June 2012, Pages: 518–525, Mary Ann Knovich, Andrew Farland and John Owen

    Version of Record online : 29 MAR 2012, DOI: 10.1111/j.1600-0609.2012.01767.x

  17. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency

    Journal of Clinical Apheresis

    Volume 27, Issue 6, 2012, Pages: 302–311, James N. George, Qiaofang Chen, Cassie C. Deford and Zayd Al-Nouri

    Version of Record online : 28 AUG 2012, DOI: 10.1002/jca.21248

  18. Presence of anti-ADAMTS13 antibodies in obesity

    European Journal of Clinical Investigation

    Volume 42, Issue 11, November 2012, Pages: 1197–1204, Anna M. Lombardi, Roberto Fabris, Alessandro Scarda, Veronica Zanato, Chiara Dal Prà, Pamela Scarparo, Silvia Vettore, Marnie Granzotto, Giulia Berti De Marinis, Mirto Foletto, Roberto Serra, Maria T. Sartori, Mario Plebani, Fabrizio Fabris and Roberto Vettor

    Version of Record online : 8 SEP 2012, DOI: 10.1111/j.1365-2362.2012.02710.x

  19. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura

    Transfusion

    Volume 56, Issue 2, February 2016, Pages: 354–359, Nathan T. Connell, Tracey Cheves and Joseph D. Sweeney

    Version of Record online : 12 OCT 2015, DOI: 10.1111/trf.13359

  20. You have full text access to this OnlineOpen article
    Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research

    Journal of Clinical Apheresis

    Volume 29, Issue 3, June 2014, Pages: 148–167, Ravi Sarode, Nick Bandarenko, Mark E. Brecher, Joseph E. Kiss, Marisa B. Marques, Zbigniew M. Szczepiorkowski and Jeffrey L. Winters

    Version of Record online : 17 OCT 2013, DOI: 10.1002/jca.21302